发明名称 |
1-SUBSTITUTED-7-( -D-GLYCOPYRANOSYLOXY)(AZA)INDOLE COMPOUND AND PHARMACEUTICAL CONTAINING THE SAME |
摘要 |
[Objective] The present invention provides a compound having an SGLT1 and/or SGLT2 inhibitory activity which is usable as an agent for the prevention or treatment of diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications, obesity or the like. [Means to Solve the Problem] It is a 1-substituted-7-(²-D-glycopyranosyloxy)(aza)-indole compound represented by the general formula (I), a prodrug thereof, or a pharmaceutically acceptable salt thereof, or a hydrate or solvate thereof:
wherein R 1 represents a halogen atom or the like; n represents an integer number from 0 to 3; R 2 represents a hydrogen atom or the like; X represents a carbon atom which a hydrogen atom or the like binds to, or a nitrogen atom; Q represents an alkylene group or an alkenylene group each of which may have an oxygen atom or a sulfur atom in the chain; and A represents an aryl or heteroaryl group which may have a substituent.
|
申请公布号 |
EP1849795(A1) |
申请公布日期 |
2007.10.31 |
申请号 |
EP20060713625 |
申请日期 |
2006.02.14 |
申请人 |
KISSEI PHARMACEUTICAL CO., LTD. |
发明人 |
FUSHIMI, NOBUHIKO;YONEKUBO, SHIGERU;OHNO, KOHSUKE |
分类号 |
C07H17/02;A61K31/7056;A61K45/00;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P5/48;A61P7/10;A61P9/10;A61P9/12;A61P19/06 |
主分类号 |
C07H17/02 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|